|
|
Innovent Biologics Inc
OTC •
Healthcare •
Biotechnology •
Quote as of 05/22/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization18,734 mln
Float1,610 mln
Earnings Date03/26/2026
P / E
148
Highly speculative
Key Fundamentals
EPS0.07
P/E148
ROE5.18
RPS1.05
ROIC12.68
ROA2.94
Interest Cover25.46
EBITDA, mln165
EV / EBITDA100
EV / EBIT130
Revenue, mln1,835
EV / Revenue9.06
Financial Strength
Altman Z-Score9.51
Piotroski F-Score
6
/ 9
Beneish M-Score-2.13
Price to Graham Number7.50
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-1.69% |
39
/ 100
 |
| 1 Month |
-11.62% |
21
/ 100
 |
| 2 Months |
1.08% |
57
/ 100
 |
| 6 Months |
-20.83% |
23
/ 100
|
| 1 Year |
91.48% |
81
/ 100
 |
|
| |
